These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1495 related articles for article (PubMed ID: 22197856)
1. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. Husby S; Koletzko S; Korponay-Szabó IR; Mearin ML; Phillips A; Shamir R; Troncone R; Giersiepen K; Branski D; Catassi C; Lelgeman M; Mäki M; Ribes-Koninckx C; Ventura A; Zimmer KP; ; ; J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):136-60. PubMed ID: 22197856 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population. Gidrewicz D; Potter K; Trevenen CL; Lyon M; Butzner JD Am J Gastroenterol; 2015 May; 110(5):760-7. PubMed ID: 25823767 [TBL] [Abstract][Full Text] [Related]
3. Are ESPGHAN "biopsy-sparing" guidelines for celiac disease also suitable for asymptomatic patients? Trovato CM; Montuori M; Anania C; Barbato M; Vestri AR; Guida S; Oliva S; Mainiero F; Cucchiara S; Valitutti F Am J Gastroenterol; 2015 Oct; 110(10):1485-9. PubMed ID: 26372508 [TBL] [Abstract][Full Text] [Related]
4. Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome. Wouters J; Weijerman ME; van Furth AM; Schreurs MW; Crusius JB; von Blomberg BM; de Baaij LR; Broers CJ; Gemke RJ J Pediatr; 2009 Feb; 154(2):239-42. PubMed ID: 18822429 [TBL] [Abstract][Full Text] [Related]
6. Coeliac disease in the ERA of the new ESPGHAN and BSPGHAN guidelines: a prospective cohort study. Benelli E; Carrato V; Martelossi S; Ronfani L; Not T; Ventura A Arch Dis Child; 2016 Feb; 101(2):172-6. PubMed ID: 26578746 [TBL] [Abstract][Full Text] [Related]
7. Interpretation and implementation of the revised European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guidelines on pediatric celiac disease amongst consultant general pediatricians in Southwest of England. Paul SP; Adams HL; Basude D; Indian J Gastroenterol; 2019 Jun; 38(3):203-210. PubMed ID: 31183842 [TBL] [Abstract][Full Text] [Related]
8. Role of HLA-DQ typing and anti-tissue transglutaminase antibody titers in diagnosing celiac disease without duodenal biopsy in type 1 diabetes: A study of the population-based pediatric type 1 diabetes cohort of Western Australia. Joshi KK; Haynes A; Davis EA; D'Orsogna L; McLean-Tooke A Pediatr Diabetes; 2019 Aug; 20(5):567-573. PubMed ID: 30985044 [TBL] [Abstract][Full Text] [Related]
9. Prudence is necessary in the application of the new ESPGHAN criteria for celiac disease omitting duodenal biopsy: a case report. Schirru E; Jores RD; Congia M Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):679-80. PubMed ID: 24694761 [TBL] [Abstract][Full Text] [Related]
10. Celiac disease: the new proposed ESPGHAN diagnostic criteria do work well in a selected population. Klapp G; Masip E; Bolonio M; Donat E; Polo B; Ramos D; Ribes-Koninckx C J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):251-6. PubMed ID: 23111763 [TBL] [Abstract][Full Text] [Related]
11. Coeliac disease diagnosis: ESPGHAN 1990 criteria or need for a change? Results of a questionnaire. Ribes-Koninckx C; Mearin ML; Korponay-Szabó IR; Shamir R; Husby S; Ventura A; Branski D; Catassi C; Koletzko S; Mäki M; Troncone R; Zimmer KP; J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):15-9. PubMed ID: 21716133 [TBL] [Abstract][Full Text] [Related]
12. Limited role of HLA DQ2/8 genotyping in diagnosing coeliac disease. Paul SP; Hoghton M; Sandhu B Scott Med J; 2017 Feb; 62(1):25-27. PubMed ID: 28084899 [TBL] [Abstract][Full Text] [Related]
13. Applicability of the New ESPGHAN Guidelines for Diagnosing Coeliac Disease in Children from Resource Limited Countries. Paul SP; Mazhar H; Spray CH J Coll Physicians Surg Pak; 2015 Jun; 25(6):455-7. PubMed ID: 26101002 [TBL] [Abstract][Full Text] [Related]
14. Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups. Kurppa K; Salminiemi J; Ukkola A; Saavalainen P; Löytynoja K; Laurila K; Collin P; Mäki M; Kaukinen K J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):387-91. PubMed ID: 22094901 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance of HLA-DQ typing in patients with previous coeliac disease diagnosis based on histology alone. Kapitány A; Tóth L; Tumpek J; Csípo I; Sipos E; Woolley N; Partanen J; Szegedi G; Oláh E; Sipka S; Korponay-Szabó IR Aliment Pharmacol Ther; 2006 Nov; 24(9):1395-402. PubMed ID: 17059521 [TBL] [Abstract][Full Text] [Related]
16. HLA-DQ types of celiac disease in Libyan children with type 1 diabetes mellitus. Ghawil M; Miotti V; Tonutti E; Tenore A; Hadeed I; Sindici C; Visentini D; Morgham A; Abusrewil S Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):59-63. PubMed ID: 22002004 [TBL] [Abstract][Full Text] [Related]
17. Estimation of the celiac disease prevalence in Denmark and the diagnostic value of HLA-DQ2/DQ8. Lund F; Pedersen MF; Kristiansen S Scand J Clin Lab Invest; 2020 Dec; 80(8):667-671. PubMed ID: 33043706 [TBL] [Abstract][Full Text] [Related]
18. Early developing celiac disease in children with cerebral palsy. Stenberg R; Kaukinen K; Bengtsson M; Lindberg E; Dahle C J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):674-8. PubMed ID: 21697743 [TBL] [Abstract][Full Text] [Related]